PedAM
Pediatric Disease Annotations & Medicines
| Disease | ovarian cancer |
| Phenotype | C0021845|bowel perforation |
| Sentences | 2 |
| PubMedID- 21778323 | Discussion: despite previous experience of a high rate of bowel perforations in patients with ovarian cancer treated with bevacizumab, no perforation was observed in this analysis despite the fact that this collective was a heavily pretreated and platinum resistant subgroup. |
| PubMedID- 20382413 | Background: increased rates of bowel perforation in patients with recurrent epithelial ovarian cancer (eoc) treated with bevacizumab have been reported, but the risk factors for this association are uncertain. |
Page: 1